Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders.


Journal

Alzheimer disease and associated disorders
ISSN: 1546-4156
Titre abrégé: Alzheimer Dis Assoc Disord
Pays: United States
ID NLM: 8704771

Informations de publication

Date de publication:
Historique:
pubmed: 13 9 2019
medline: 29 7 2020
entrez: 13 9 2019
Statut: ppublish

Résumé

A rare variant in TREM2 (p.R47H, rs75932628) has been consistently reported to increase the risk for Alzheimer disease (AD), while mixed evidence has been reported for association of the variant with other neurodegenerative diseases. Here, we investigated the frequency of the R47H variant in a diverse and well-characterized multicenter neurodegenerative disease cohort. We examined the frequency of the R47H variant in a diverse neurodegenerative disease cohort, including a total of 3058 patients clinically diagnosed with AD, frontotemporal dementia spectrum syndromes, mild cognitive impairment, progressive supranuclear palsy syndrome, corticobasal syndrome, or amyotrophic lateral sclerosis and 5089 control subjects. We observed a significant association between the R47H variant and AD, while no association was observed with any other neurodegenerative disease included in this study. Our results support the consensus that the R47H variant is significantly associated with AD. However, we did not find evidence for association of the R47H variant with other neurodegenerative diseases.

Identifiants

pubmed: 31513029
doi: 10.1097/WAD.0000000000000339
pmc: PMC7050643
mid: NIHMS1535727
doi:

Substances chimiques

Membrane Glycoproteins 0
Receptors, Immunologic 0
TREM2 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-330

Subventions

Organisme : NIA NIH HHS
ID : RC1 AG035610
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG023501
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG058233
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG000538
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062422
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG019724
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH097268
Pays : United States
Organisme : NINDS NIH HHS
ID : UG3 NS104095
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG025688
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG015819
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG021886
Pays : United States
Organisme : NINDS NIH HHS
ID : F31 NS084556
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG017917
Pays : United States
Organisme : NINDS NIH HHS
ID : P30 NS062691
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010161
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG032289
Pays : United States

Références

Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Nat Genet. 2013 Dec;45(12):1452-8
pubmed: 24162737
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Nat Genet. 2017 Sep;49(9):1373-1384
pubmed: 28714976
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
N Engl J Med. 2013 Jan 10;368(2):117-27
pubmed: 23150934
Alzheimers Dement. 2015 Dec;11(12):1407-1416
pubmed: 25936935
Neurobiol Aging. 2013 Jun;34(6):1711.e15-7
pubmed: 23391427
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Alzheimers Dement. 2014 Nov;10(6):602-608.e4
pubmed: 25160042
Neurobiol Aging. 2017 Nov;59:220.e1-220.e9
pubmed: 28789839
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
JAMA Neurol. 2014 Apr;71(4):449-53
pubmed: 24535663
Immunity. 2017 Sep 19;47(3):566-581.e9
pubmed: 28930663
Mol Neurodegener. 2017 Aug 2;12(1):56
pubmed: 28768545
N Engl J Med. 2013 Jan 10;368(2):107-16
pubmed: 23150908
Neurobiol Aging. 2014 Feb;35(2):444.e1-4
pubmed: 24041969
JAMA Neurol. 2015 Aug;72(8):920-7
pubmed: 26076170
Mol Neurodegener. 2013 Jun 21;8:19
pubmed: 23800361

Auteurs

Ariane H Ayer (AH)

Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine.

Kevin Wojta (K)

Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine.

Eliana Marisa Ramos (EM)

Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine.

Deepika Dokuru (D)

Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine.

Jason A Chen (JA)

Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine.

Anna M Karydas (AM)

Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA.

John D Papatriantafyllou (JD)

Third Age Day Care Center IASIS, Athens, Greece Memory Clinic, Medical Center of Athens, Greece.

Dimitrios Agiomyrgiannakis (D)

Third Age Day Care Center IASIS, Athens, Greece Memory Clinic, Medical Center of Athens, Greece.

Vasiliki Kamtsadeli (V)

Third Age Day Care Center IASIS, Athens, Greece Memory Clinic, Medical Center of Athens, Greece.

Niki Tsinia (N)

Third Age Day Care Center IASIS, Athens, Greece Memory Clinic, Medical Center of Athens, Greece.

Dimitra Sali (D)

Third Age Day Care Center IASIS, Athens, Greece Memory Clinic, Medical Center of Athens, Greece.

Karen H Gylys (KH)

Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine.

Federica Agosta (F)

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Massimo Filippi (M)

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Gary W Small (GW)

Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine.

David A Bennett (DA)

Department of Neurological Sciences and Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.

Marla Gearing (M)

Department of Neurology, Department of Pathology, and Department of Laboratory Medicine, Emory University, Atlanta, GA.

Jorge L Juncos (JL)

Department of Neurology, Department of Pathology, and Department of Laboratory Medicine, Emory University, Atlanta, GA.

Joel Kramer (J)

Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA.

Suzee E Lee (SE)

Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA.

Jennifer S Yokoyama (JS)

Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA.

Mario F Mendez (MF)

Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine.

Helena Chui (H)

Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles.

Chris Zarow (C)

Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles.

John M Ringman (JM)

Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles.
Department of Neurology, University of California Los Angeles.

Ulkan Kilic (U)

Department of Medical Biology, Faculty of Medicine, University of Health Sciences.

Gülsen Babacan-Yildiz (G)

Department of Neurology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.

Allan Levey (A)

Department of Neurology, Department of Pathology, and Department of Laboratory Medicine, Emory University, Atlanta, GA.

Charles S DeCarli (CS)

Department of Neurology, School of Medicine, University of California, Davis.

Carl W Cotman (CW)

Department of Neurology, School of Medicine, University of California, Irvine.

Adam L Boxer (AL)

Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA.

Bruce L Miller (BL)

Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA.

Giovanni Coppola (G)

Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine.
Department of Neurology, University of California Los Angeles.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH